Rushed through last minute before parliament is dissolved using emergency powers.

Should’ve been debated in the commons at least.

  • LainTrain@lemmy.dbzer0.com
    link
    fedilink
    English
    arrow-up
    1
    arrow-down
    1
    ·
    6 months ago

    That is a pointless difference in practice, because kids who suffer from gender dysphoria would use these meds for treatment of said dysphoria and do in the rest of the world that follows the expert guidance from WPATH, and now they can’t, and the kids will suffer as a result. But hey at least the transes will be mad innit.

    • streetlights@lemmy.worldOP
      link
      fedilink
      English
      arrow-up
      1
      ·
      6 months ago

      It is not a pointless difference. The use of gonadotropin-releasing hormone (GnRH) agonists have been banned in the UK for the treatment of gender dysphoria. They are of course still available for treating precocious puberty, regardless of how anyone identifies.